Neurochem (NRM-T) Stock Predictions - Stockchase
WATCH LIST
11
Neurochem (NRM-T)

ON STOCKCHASE SINCE Jan 2003

biotechnology/pharmaceutical

Neurochem

NRM-T

0 watching          
Join the Discussion

Neurochem (NRM-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about NRM-T



  • All
  • Filtered
Signal Opinion Expert
SELL
Neurochem(NRM-T) 

February 23, 2006

He likes it, the only downside is that because the Japaneese market has risen 40% over the last year, it's a bit expensive right now. He suggests going to a different fund which is not so centered on the Japaneese market.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
He likes it, the only downside is that because the Japaneese market has risen 40% over the last year, it's a bit expensive right now. He suggests going to a different fund which is not so centered on the Japaneese market.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Driscoll

President , Liberty Internationa...

Price Price
$17.600
Owned Owned
Unknown

DON'T BUY
Neurochem(NRM-T) 

April 27, 2005

Looking at his relative performer chart, it's been an underperformer. Has negative money flow. In a very clear downtrend.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Looking at his relative performer chart, it's been an underperformer. Has negative money flow. In a very clear downtrend.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bill Carrigan

Technical , Getting Technical In...

Price Price
$9.160
Owned Owned
No

BUY
Neurochem(NRM-T) 

July 28, 2004

There has been a general selloff of biotech stocks. Still believe in this company.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
There has been a general selloff of biotech stocks. Still believe in this company.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Michael Smedley

Exec VP & , Morgan Meighan & Ass...

Price Price
$22.850
Owned Owned
Yes

DON'T BUY
Neurochem(NRM-T) 

July 8, 2004

Feels it's a little pricey at these levels given where they are in the development of their program. Have some interesting programs.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Feels it's a little pricey at these levels given where they are in the development of their program. Have some interesting programs.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Andrew McCreath

Senior Por, Sentry Select Capita...

Price Price
$28.680
Owned Owned
No

BUY
Neurochem(NRM-T) 

March 23, 2004

Has been moving sideways which, for a biotech, is not too bad. The company has good backing. Should see considerable upside.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has been moving sideways which, for a biotech, is not too bad. The company has good backing. Should see considerable upside.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Michael Smedley

Exec VP & , Morgan Meighan & Ass...

Price Price
$26.600
Owned Owned
Unknown

PAST TOP PICK
Neurochem(NRM-T) 

January 23, 2004

(A top pick Sept 9/03. Up100 %.) Still likes. The market opportunity is so big, would still buy at this price.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A top pick Sept 9/03. Up100 %.) Still likes. The market opportunity is so big, would still buy at this price.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$29.100
Owned Owned
Yes

PAST TOP PICK
Neurochem(NRM-T) 

December 4, 2003

(A top pick Sept 9/03. Up 58%.) As a potential treatment for Alzheimer's. Good technology. Has some US financing which will get US investors interested.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A top pick Sept 9/03. Up 58%.) As a potential treatment for Alzheimer's. Good technology. Has some US financing which will get US investors interested.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$22.910
Owned Owned
Yes

TOP PICK
Neurochem(NRM-T) 

September 9, 2003

Into phase 3 trial. All cashed up. Will start to be getting attention.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Into phase 3 trial. All cashed up. Will start to be getting attention.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$14.200
Owned Owned
Yes

BUY
Neurochem(NRM-T) 

August 8, 2003

Has a very strong range of products.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has a very strong range of products.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Michael Smedley

Exec VP & , Morgan Meighan & Ass...

Price Price
$12.970
Owned Owned
Yes

HOLD
Neurochem(NRM-T) 

January 20, 2003

Has gone up quite well and may stay level for awhile.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has gone up quite well and may stay level for awhile.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Pierre Bernard

Vice Presi, Industrial Alliance ...

Price Price
$8.400
Owned Owned
Unknown

TOP PICK
Neurochem(NRM-T) 

January 14, 2003

Likes the managemnt. Big financial support.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Likes the managemnt. Big financial support.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Michael Smedley

Exec VP & , Morgan Meighan & Ass...

Price Price
$8.320
Owned Owned
Unknown

Showing 1 to 11 of 11 entries
Successfully Saved Company
Successfully Saved Company